NanoVation-GS

RPM and early exacerbations alert for optimal management of respiratory patients

Startup

NanoVation-GS is a Haifa-based startup in the Health Tech & Life Sciences sector, established in 2014. RPM and early exacerbations alert for optimal management of respiratory patients. The company has raised a total of $8.76M across 7 funding rounds, currently at the Seed stage. NanoVation-GS was founded by Gregory Shuster, Hossam Haick, Nadav Bachar. Key investors include ExitValley, European Innovation Council (EIC), Undisclosed Investor(s). The company has 1-10 employees. Core technologies: Materials & Substances, Nanomaterials, Semiconductors & Electronics, Wearables, Sensing.

With $8.76M in total funding, NanoVation-GS is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Beta. The company holds 1 patent.

$8.76M
Raised
7
Rounds
3
Investors
3
Team
2014
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesMedical DevicesMedical MonitorsDiagnostics DevicesDigital HealthcarePatient Remote MonitoringMaterials & SubstancesNanomaterialsSemiconductors & ElectronicsWearablesSensing
At a Glance
Investors
Founders
In the News

5 articles covered by sources including www.jpost.com, www.calcalistech.com, www.thetower.org, www.israel21c.org.

www.jpost.com · Jul 19, 2022
https://www.jpost.com/israel-news/article-712509
Read article ↗
Frequently Asked Questions
What does NanoVation-GS do?

NanoVation-GS is a med-tech startup aiming to help alleviate the suffering of hundreds of millions of patients and reduce the high financial burden due to frequent hospitalizations of chronic respiratory patients such as COPD and asthma. SenseGuard™, developed by NanoVation-GS, is a reliable and patient-friendly solution for monitoring patients’ respiratory condition, measuring unique lung function biomarkers from effortless (tidal) breathing. Short measurements of 2-3 minutes once a day, enable disease management and early detection and treatment of exacerbations, before they reach acute stage that requires hospitalization.

How much funding has NanoVation-GS raised?

NanoVation-GS has raised $8.76M in total funding across 7 rounds. The company is currently at the Seed stage. Key investors include ExitValley, European Innovation Council (EIC), Undisclosed Investor(s).

Who founded NanoVation-GS?

NanoVation-GS was founded in 2014 by Gregory Shuster (Co-founder & CEO), Hossam Haick (Co-founder & CSO), Nadav Bachar (Co-founder & CTO).

What sector is NanoVation-GS in?

NanoVation-GS operates in Health Tech & Life Sciences, Medical Devices, Medical Monitors, Diagnostics Devices, Digital Healthcare, Patient Remote Monitoring, with core technologies in Materials & Substances, Nanomaterials, Semiconductors & Electronics, Wearables, Sensing. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Insurance Companies, Patients.

Where is NanoVation-GS located?

NanoVation-GS is based in Khuri St 2, Haifa, Israel, North District.

View Full Profile Classic View Website ↗